Lysosomal storage of heparan sulfate causes mitochondrial defects, altered autophagy, and neuronal death in the mouse model of mucopolysaccharidosis III type C.

Abstract

The genetic metabolic disease mucopolysaccharidosis III type C (MPS IIIC, Sanfilippo disease type C) causes progressive neurodegeneration in infants and children, leading to dementia and death before adulthood. MPS IIIC stands out among lysosomal diseases because it is the only one caused by a deficiency not of a hydrolase but of HGSNAT (heparan--glucosaminide N-acetyltransferase), which catalyzes acetylation of glycosaminoglycan heparan sulfate (HS) prior to its hydrolysis.

• Authors: Alexey V Pshezhetsky
• Journal: Autophagy (Autophagy) Vol. 12 Issue 6 Pg. 1059-60 (06 02 2016) ISSN: 1554-8635 [Electronic] United States
• PMID: 25998837 (Publication Type: Journal Article)

Chemical References

• Heparitin Sulfate

Topics

• Animals
• Autophagy
• Brain (pathology)
• Cell Death
• Disease Models, Animal
• Heparitin Sulfate (metabolism)
• Humans
• Lysosomes (metabolism)
• Mice
• Mice, Knockout
• Mitochondria (metabolism, pathology)
• Mucopolysaccharidosis III (metabolism, pathology)
• Neurons (metabolism, pathology)